Filing Flows › China Pharma Holdings (CPHI) › Q1 2025
China Pharma Holdings (CPHI) Q1 2025 earnings results (first quarter 2025)
10-Q filed May 14, 2025
China Pharma Holdings (CPHI) reported revenue of $1.1M for the first quarter 2025 (Q1 2025), -17% from a year earlier and +0.2% from the quarter before. Operating margin was -66.8%, net loss $786K (69.1% of revenue).
China Pharma Holdings, Q1 2025: revenue $1.1M (-17% year over year), operating margin -66.8%, net loss $786K, operating cash flow −$58K. The chart follows the revenue to costs, profit and cash.
| Q1 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.1M | +0.2% | -17% |
| Operating profit | −$759K | — | — |
| Net earnings | −$786K | — | — |
| Operating cash flow | −$58K | -124% | — |
What changed
Revenue was $1.1M in Q1 2025, down 17% year over year and roughly flat from the previous quarter.
Operating costs exceeded revenue by $759K, an operating margin of -66.8%. Total costs fell 17% while revenue fell 17%. The quarter ended with a net loss of $786K, narrower than the previous quarter's $1.2M loss.
Operating cash flow was −$58K. Non-cash charges added back $329K of depreciation and amortization. Working capital and other items added $398K. Capital expenditures of $58K exceeded it, leaving free cash flow of −$116K.
Questions
What was China Pharma Holdings' revenue in the first quarter 2025?
China Pharma Holdings (CPHI) reported revenue of $1.1M for the first quarter 2025 (Q1 2025), -17% from a year earlier and +0.2% from the quarter before.
Was China Pharma Holdings profitable in the first quarter 2025?
Operating loss was $759K (-66.8% of revenue) and net loss $786K.